Literature DB >> 17824980

Increased apoptosis and decreased proliferation of colorectal cancer cells using insulin-like growth factor binding protein-4 gene delivered locally by gene transfer.

R Durai1, S Y Yang, K M Sales, A M Seifalian, G Goldspink, M C Winslet.   

Abstract

OBJECTIVE: Insulin-like growth factor (IGF)-I induces proliferation of transformed cells. Its binding proteins (IGFBP) are involved in local regulation of IGF. This study assessed the effects of overexpression of IGFBP-4 on the development of cancer in vivo.
METHOD: Nude mice were subcutaneously inoculated with HT-29 colorectal cancer cells (3 x 10(6)). When the tumour became visible (1 week after inoculation), animals received either 150 microg of mammalian expression vector containing IGFBP-4 cDNA or vector alone (n = 6 each) by peritumoural injection. Tumour size was measured during the growth. After 3 weeks of IGFBP-4 induction, animals were killed and tumour tissue samples were collected for examining the level of IGFBP-4 expression. Tumour mitotic activities were determined by counting numbers of mitotic cells on the tissue section. Apoptosis was investigated by terminal deoxynucleotidyl transferase-mediated dUDP nick end labelling assay.
RESULTS: Following IGFBP-4 treatment, tumour showed large necrotic areas, significantly increased numbers of apoptotic cells (36.67 +/- 7.36 vs 7.07 +/- 1.91, P < 0.01 vs control), decreased cells undergoing mitosis (2.31 +/- 0.32 vs 3.61 +/- 0.27, P < 0.01 vs control) and higher expression of IGFBP-4 (P < 0.05 vs control).
CONCLUSION: IGFBP-4 gene transfer increased apoptosis and decreased mitosis, but tumour volume was not significantly altered possibly due to cellular debris filling the centre of tumours.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17824980     DOI: 10.1111/j.1463-1318.2006.01190.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  6 in total

1.  The igf system in carcinogenesis and its implication for cancer therapy.

Authors:  S Y Yang; M Winslet
Journal:  Curr Oncol       Date:  2011-12       Impact factor: 3.677

2.  Synthesis of aryl-heteroaryl ureas (AHUs) based on 4-aminoquinoline and their evaluation against the insulin-like growth factor receptor (IGF-1R).

Authors:  William Engen; Terrence E O'Brien; Brendan Kelly; Jacinda Do; Liezel Rillera; Lance K Stapleton; Jack F Youngren; Marc O Anderson
Journal:  Bioorg Med Chem       Date:  2010-06-25       Impact factor: 3.641

Review 3.  Growth hormone, the insulin-like growth factor axis, insulin and cancer risk.

Authors:  Peter E Clayton; Indraneel Banerjee; Philip G Murray; Andrew G Renehan
Journal:  Nat Rev Endocrinol       Date:  2010-10-19       Impact factor: 43.330

4.  SOX9 directly regulates IGFBP-4 in the intestinal epithelium.

Authors:  Zhongcheng Shi; Chi-I Chiang; Toni-Ann Mistretta; Angela Major; Yuko Mori-Akiyama
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-05-09       Impact factor: 4.052

5.  Overexpression of lncRNA IGFBP4-1 reprograms energy metabolism to promote lung cancer progression.

Authors:  Binyao Yang; Lisha Zhang; Yi Cao; Shuai Chen; Jun Cao; Di Wu; Jiansong Chen; Huali Xiong; Zihua Pan; Fuman Qiu; Jinbin Chen; Xiaoxuan Ling; Maosheng Yan; Suli Huang; Shiyu Zhou; Tiegang Li; Lei Yang; Yunchao Huang; Jiachun Lu
Journal:  Mol Cancer       Date:  2017-09-25       Impact factor: 27.401

6.  Role of insulin-like growth factor binding protein-4 in prevention of colon cancer.

Authors:  Rajaraman Durai; Shi Y Yang; Alexander M Seifalian; Geoffrey Goldspink; Marc C Winslet
Journal:  World J Surg Oncol       Date:  2007-11-07       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.